Initial Experience with Narcotic-Free Ureteroscopy: A Feasibility Analysis

Tim Large, Joshua Heiman, Ashley Ross, Blake Anderson, Amy Krambeck

Research output: Contribution to journalArticle

Abstract

Background and Purpose: In the United States, there is an opioid abuse epidemic fueled by prescription medications. Concerns that uncontrolled pain after surgical procedures will result in poor patient satisfaction and increased workload for ancillary staff are potential factors that influence provider prescription habits. Currently, there is a paucity of literature on analgesic requirements after ureteroscopy (URS) for nephrolithiasis. Our study objective was to evaluate the safety of narcotic-free ureteroscopy (nf-URS) and assess its impact on provider workload. Methods: We performed a retrospective chart review of 104 patients, between October 2017 and May 2018, who underwent URS and who required a stent postprocedure. Starting February 2018, patients without absolute contraindication or allergies to nonsteroidal anti-inflammatory drugs received a prescription for diclofenac instead of hydrocodone or oxycodone. Postoperative phone calls to nurses and residents, emergency room visits, and prescription monitoring reports were evaluated for all patients, and compared between the nf-URS and the standard ureteroscopy (s-URS). Results: There were 52 nf-URS and 52 s-URS procedures. In the postoperative period, 9 (17%) nf-URS and 10 (19%) s-URS patients called with postoperative pain issues. Five (10%) nf-URS vs 9 (17%) s-URS patients obtained narcotics after seeking additional medical care after URS because of inadequate pain control. There were no postoperative complications in our cohort. Compared with s-URS, 6871.5 mg less of morphine equivalent dosage (1375 hydrocodone tablets) was administered to nf-URS patients immediately after surgery. Conclusions: Attempts to reduce the number of narcotic prescriptions are paramount in the fight against narcotic addiction in the United States. Although our initial cohort is small, this feasibility study provides compelling evidence that nf-URS is a safe and effective practice. Furthermore, nf-URS resulted in a dramatic decrease in the number of narcotics circulating in the community.

Original languageEnglish (US)
Pages (from-to)907-911
Number of pages5
JournalJournal of Endourology
Volume32
Issue number10
DOIs
StatePublished - Oct 1 2018

Fingerprint

Ureteroscopy
Narcotics
Prescriptions
Hydrocodone
Workload
Oxycodone
Opioid-Related Disorders
Pain
Nephrolithiasis
Diclofenac

Keywords

  • narcotics
  • nephrolithiasis
  • opioids
  • surgery
  • ureteroscopy

ASJC Scopus subject areas

  • Urology

Cite this

Initial Experience with Narcotic-Free Ureteroscopy : A Feasibility Analysis. / Large, Tim; Heiman, Joshua; Ross, Ashley; Anderson, Blake; Krambeck, Amy.

In: Journal of Endourology, Vol. 32, No. 10, 01.10.2018, p. 907-911.

Research output: Contribution to journalArticle

Large, Tim ; Heiman, Joshua ; Ross, Ashley ; Anderson, Blake ; Krambeck, Amy. / Initial Experience with Narcotic-Free Ureteroscopy : A Feasibility Analysis. In: Journal of Endourology. 2018 ; Vol. 32, No. 10. pp. 907-911.
@article{6ce2c3c6b76e41a7a133bc705e3d3f0f,
title = "Initial Experience with Narcotic-Free Ureteroscopy: A Feasibility Analysis",
abstract = "Background and Purpose: In the United States, there is an opioid abuse epidemic fueled by prescription medications. Concerns that uncontrolled pain after surgical procedures will result in poor patient satisfaction and increased workload for ancillary staff are potential factors that influence provider prescription habits. Currently, there is a paucity of literature on analgesic requirements after ureteroscopy (URS) for nephrolithiasis. Our study objective was to evaluate the safety of narcotic-free ureteroscopy (nf-URS) and assess its impact on provider workload. Methods: We performed a retrospective chart review of 104 patients, between October 2017 and May 2018, who underwent URS and who required a stent postprocedure. Starting February 2018, patients without absolute contraindication or allergies to nonsteroidal anti-inflammatory drugs received a prescription for diclofenac instead of hydrocodone or oxycodone. Postoperative phone calls to nurses and residents, emergency room visits, and prescription monitoring reports were evaluated for all patients, and compared between the nf-URS and the standard ureteroscopy (s-URS). Results: There were 52 nf-URS and 52 s-URS procedures. In the postoperative period, 9 (17{\%}) nf-URS and 10 (19{\%}) s-URS patients called with postoperative pain issues. Five (10{\%}) nf-URS vs 9 (17{\%}) s-URS patients obtained narcotics after seeking additional medical care after URS because of inadequate pain control. There were no postoperative complications in our cohort. Compared with s-URS, 6871.5 mg less of morphine equivalent dosage (1375 hydrocodone tablets) was administered to nf-URS patients immediately after surgery. Conclusions: Attempts to reduce the number of narcotic prescriptions are paramount in the fight against narcotic addiction in the United States. Although our initial cohort is small, this feasibility study provides compelling evidence that nf-URS is a safe and effective practice. Furthermore, nf-URS resulted in a dramatic decrease in the number of narcotics circulating in the community.",
keywords = "narcotics, nephrolithiasis, opioids, surgery, ureteroscopy",
author = "Tim Large and Joshua Heiman and Ashley Ross and Blake Anderson and Amy Krambeck",
year = "2018",
month = "10",
day = "1",
doi = "10.1089/end.2018.0459",
language = "English (US)",
volume = "32",
pages = "907--911",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Initial Experience with Narcotic-Free Ureteroscopy

T2 - A Feasibility Analysis

AU - Large, Tim

AU - Heiman, Joshua

AU - Ross, Ashley

AU - Anderson, Blake

AU - Krambeck, Amy

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Background and Purpose: In the United States, there is an opioid abuse epidemic fueled by prescription medications. Concerns that uncontrolled pain after surgical procedures will result in poor patient satisfaction and increased workload for ancillary staff are potential factors that influence provider prescription habits. Currently, there is a paucity of literature on analgesic requirements after ureteroscopy (URS) for nephrolithiasis. Our study objective was to evaluate the safety of narcotic-free ureteroscopy (nf-URS) and assess its impact on provider workload. Methods: We performed a retrospective chart review of 104 patients, between October 2017 and May 2018, who underwent URS and who required a stent postprocedure. Starting February 2018, patients without absolute contraindication or allergies to nonsteroidal anti-inflammatory drugs received a prescription for diclofenac instead of hydrocodone or oxycodone. Postoperative phone calls to nurses and residents, emergency room visits, and prescription monitoring reports were evaluated for all patients, and compared between the nf-URS and the standard ureteroscopy (s-URS). Results: There were 52 nf-URS and 52 s-URS procedures. In the postoperative period, 9 (17%) nf-URS and 10 (19%) s-URS patients called with postoperative pain issues. Five (10%) nf-URS vs 9 (17%) s-URS patients obtained narcotics after seeking additional medical care after URS because of inadequate pain control. There were no postoperative complications in our cohort. Compared with s-URS, 6871.5 mg less of morphine equivalent dosage (1375 hydrocodone tablets) was administered to nf-URS patients immediately after surgery. Conclusions: Attempts to reduce the number of narcotic prescriptions are paramount in the fight against narcotic addiction in the United States. Although our initial cohort is small, this feasibility study provides compelling evidence that nf-URS is a safe and effective practice. Furthermore, nf-URS resulted in a dramatic decrease in the number of narcotics circulating in the community.

AB - Background and Purpose: In the United States, there is an opioid abuse epidemic fueled by prescription medications. Concerns that uncontrolled pain after surgical procedures will result in poor patient satisfaction and increased workload for ancillary staff are potential factors that influence provider prescription habits. Currently, there is a paucity of literature on analgesic requirements after ureteroscopy (URS) for nephrolithiasis. Our study objective was to evaluate the safety of narcotic-free ureteroscopy (nf-URS) and assess its impact on provider workload. Methods: We performed a retrospective chart review of 104 patients, between October 2017 and May 2018, who underwent URS and who required a stent postprocedure. Starting February 2018, patients without absolute contraindication or allergies to nonsteroidal anti-inflammatory drugs received a prescription for diclofenac instead of hydrocodone or oxycodone. Postoperative phone calls to nurses and residents, emergency room visits, and prescription monitoring reports were evaluated for all patients, and compared between the nf-URS and the standard ureteroscopy (s-URS). Results: There were 52 nf-URS and 52 s-URS procedures. In the postoperative period, 9 (17%) nf-URS and 10 (19%) s-URS patients called with postoperative pain issues. Five (10%) nf-URS vs 9 (17%) s-URS patients obtained narcotics after seeking additional medical care after URS because of inadequate pain control. There were no postoperative complications in our cohort. Compared with s-URS, 6871.5 mg less of morphine equivalent dosage (1375 hydrocodone tablets) was administered to nf-URS patients immediately after surgery. Conclusions: Attempts to reduce the number of narcotic prescriptions are paramount in the fight against narcotic addiction in the United States. Although our initial cohort is small, this feasibility study provides compelling evidence that nf-URS is a safe and effective practice. Furthermore, nf-URS resulted in a dramatic decrease in the number of narcotics circulating in the community.

KW - narcotics

KW - nephrolithiasis

KW - opioids

KW - surgery

KW - ureteroscopy

UR - http://www.scopus.com/inward/record.url?scp=85055076927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055076927&partnerID=8YFLogxK

U2 - 10.1089/end.2018.0459

DO - 10.1089/end.2018.0459

M3 - Article

C2 - 30039709

AN - SCOPUS:85055076927

VL - 32

SP - 907

EP - 911

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 10

ER -